Prestige Consumer Healthcare Inc. (PBH)
PBH trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$48.50
-1.02% on the day
Market cap
$2.3B
Mid cap
Revenue · 2025
$1.1B
-4.3% on 2024
Net income · 2025
$190.3M
17.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PBH on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2005 |
| SEC CIK | 0001295947 |
| SEC industry code | Pharmaceutical Preparations |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.1B |
| Net income | $190.3M |
| Operating income | $309.4M |
| Net margin | 17.5% |
| Operating margin | 28.4% |
| Revenue growth | -4.3% |
| Cash | $62.4M |
| Total assets | $3.5B |
| P/E (computed) | 12.1× |
| P/S (computed) | 2.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2012-07-13 |
| Latest annual report | 10-K | 2026-05-14 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-14 |
| Latest proxy | DEF 14A | 2026-06-29 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +1.3% |
| 1 month | +3.3% |
| 3 months | -4.7% |
| Year to date | -21.9% |
| 1 year | -22.0% |
| From 52-week high | -31.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NRIX | Nurix Therapeutics Inc. | $22.13 | -0.14% | $2.3B |
| HCM | HUTCHMED (China) Limited | $13.50 | -1.32% | $2.4B |
| MBX | MBX Biosciences Inc. | $49.00 | -5.80% | $2.4B |
| BHC | Bausch Health Companies Inc. | $5.89 | -0.68% | $2.2B |
| LQDA | Liquidia Corporation | $26.81 | -3.11% | $2.4B |
| NAMS | NewAmsterdam Pharma Company N.V. | $20.19 | -4.99% | $2.4B |
| AUPH | Aurinia Pharmaceuticals Inc | $16.36 | -1.15% | $2.2B |
| IRON | Disc Medicine Inc. | $56.60 | -6.42% | $2.2B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier